ZA201801708B - Treatment of diabetic peripheral neuropathy using placental cells - Google Patents

Treatment of diabetic peripheral neuropathy using placental cells

Info

Publication number
ZA201801708B
ZA201801708B ZA2018/01708A ZA201801708A ZA201801708B ZA 201801708 B ZA201801708 B ZA 201801708B ZA 2018/01708 A ZA2018/01708 A ZA 2018/01708A ZA 201801708 A ZA201801708 A ZA 201801708A ZA 201801708 B ZA201801708 B ZA 201801708B
Authority
ZA
South Africa
Prior art keywords
treatment
peripheral neuropathy
placental cells
diabetic peripheral
diabetic
Prior art date
Application number
ZA2018/01708A
Other languages
English (en)
Inventor
Steven A Fischkoff
Denesh Chitkara
Original Assignee
Celularity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celularity Inc filed Critical Celularity Inc
Publication of ZA201801708B publication Critical patent/ZA201801708B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA2018/01708A 2015-09-15 2018-03-13 Treatment of diabetic peripheral neuropathy using placental cells ZA201801708B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562218885P 2015-09-15 2015-09-15
PCT/US2016/051571 WO2017048741A1 (en) 2015-09-15 2016-09-14 Treatment of diabetic peripheral neuropathy using placental cells

Publications (1)

Publication Number Publication Date
ZA201801708B true ZA201801708B (en) 2019-01-30

Family

ID=58289824

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2018/01708A ZA201801708B (en) 2015-09-15 2018-03-13 Treatment of diabetic peripheral neuropathy using placental cells

Country Status (17)

Country Link
US (2) US20180264048A1 (enExample)
EP (2) EP3349771A4 (enExample)
JP (3) JP2018529683A (enExample)
KR (1) KR20180051631A (enExample)
CN (1) CN108367028A (enExample)
AU (1) AU2016323120A1 (enExample)
BR (1) BR112018005014B1 (enExample)
CA (1) CA2998759A1 (enExample)
CO (1) CO2018003759A2 (enExample)
EA (1) EA201890720A1 (enExample)
IL (2) IL281185B2 (enExample)
MX (1) MX2018003275A (enExample)
MY (1) MY203748A (enExample)
NZ (1) NZ740663A (enExample)
SG (1) SG10201912572VA (enExample)
WO (1) WO2017048741A1 (enExample)
ZA (1) ZA201801708B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240058180A (ko) 2021-11-10 2024-05-03 미쯔비시 케미컬 주식회사 탄소섬유, 탄소섬유속 및 탄소섬유속의 제조 방법

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190556A (en) 1991-03-19 1993-03-02 O.B. Tech, Inc. Cord cutter sampler
US5372581A (en) 1993-07-21 1994-12-13 Minneapolis Children's Services Corporation Method and apparatus for placental blood collection
KR100696407B1 (ko) 1999-04-16 2007-03-19 더블유엠. 마쉬 라이스 유니버시티 폴리(프로필렌 푸마레이트)-디아크릴레이트 마크로머와가교결합된 생분해성 폴리(프로필렌 푸마레이트) 네트워크
US6355699B1 (en) 1999-06-30 2002-03-12 Ethicon, Inc. Process for manufacturing biomedical foams
KR100915483B1 (ko) 2000-12-06 2009-09-03 로버트 제이 하리리 태반 줄기 세포의 회수 방법
US7311905B2 (en) 2002-02-13 2007-12-25 Anthrogenesis Corporation Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
JP2004528021A (ja) 2001-02-14 2004-09-16 アンスロジェネシス コーポレーション 分娩後の哺乳動物の胎盤、その使用およびそれに由来する胎盤幹細胞
ES2545899T3 (es) 2001-02-14 2015-09-16 Anthrogenesis Corporation Placenta post-parto de mamíferos, su uso y células madre placentarias de la misma
US20030187515A1 (en) 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20040161419A1 (en) * 2002-04-19 2004-08-19 Strom Stephen C. Placental stem cells and uses thereof
US7255729B2 (en) 2003-05-30 2007-08-14 Noritake Co., Limited Porous cylindrical-body module, structure for supporting porous cylindrical bodies, and method for fastening a supporting member
US7147626B2 (en) 2004-09-23 2006-12-12 Celgene Corporation Cord blood and placenta collection kit
JP2009521931A (ja) 2005-12-29 2009-06-11 アントフロゲネシス コーポレーション 胎盤幹細胞を収集及び保存するための改善された組成物、及び該組成物の使用方法
PT2471905T (pt) 2005-12-29 2019-01-11 Celularity Inc Populações de células estaminais placentárias
US20090018151A1 (en) * 2007-02-23 2009-01-15 Ezekiel Fink Topical Treatment of Peripheral diabetic complications
EP2556145B1 (en) * 2010-04-07 2016-07-20 Anthrogenesis Corporation Angiogenesis using placental stem cells
WO2012166844A2 (en) * 2011-06-01 2012-12-06 Anthrogenesis Corporation Treatment of pain using placental stem cells

Also Published As

Publication number Publication date
JP2021183635A (ja) 2021-12-02
JP2018529683A (ja) 2018-10-11
EP3349771A4 (en) 2019-04-24
US20220072063A1 (en) 2022-03-10
CN108367028A (zh) 2018-08-03
JP2023171769A (ja) 2023-12-05
WO2017048741A1 (en) 2017-03-23
US20180264048A1 (en) 2018-09-20
SG10201912572VA (en) 2020-02-27
BR112018005014B1 (pt) 2022-03-22
IL281185A (en) 2021-04-29
NZ740663A (en) 2022-12-23
EA201890720A1 (ru) 2018-09-28
BR112018005014A2 (enExample) 2018-10-02
MX2018003275A (es) 2018-05-16
EP3957315A1 (en) 2022-02-23
AU2016323120A1 (en) 2018-04-12
IL281185B1 (en) 2024-01-01
KR20180051631A (ko) 2018-05-16
IL258048A (en) 2018-05-31
MY203748A (en) 2024-07-17
CA2998759A1 (en) 2017-03-23
EP3349771A1 (en) 2018-07-25
IL281185B2 (en) 2024-05-01
CO2018003759A2 (es) 2018-12-14

Similar Documents

Publication Publication Date Title
IL253795A0 (en) Methods for treating cancer using activated t cells
IL253803B (en) A preparation for the treatment of hypothyroidism
EP3261713A4 (en) Blood pump for treatment of bradycardia
EP3145875A4 (en) Electrochemical treatment methods
EP3116484A4 (en) Treating diseases using nitric oxide releasing solutions
EP3297653A4 (en) Treatment of post-bariatric hypoglycemia with glp-1 antagonists
IL259486A (en) Substances for the treatment of diseases associated with unwanted cell proliferation
IL255834A (en) Electrochemical biosensor
IL292054A (en) Compositions for treatment of abnormal cell growth
EP3228302A4 (en) Hair deformation treatment agent
EP3228303A4 (en) Hair deformation treatment agent
IL254825A0 (en) Methods of treatment with Tesalisib
EP3228300A4 (en) Hair deformation treatment agent
HUE052584T2 (hu) Pluripotens õssejt diabéteszes bõrfekély kezelésére
GB201519450D0 (en) Novel treatment
GB201522223D0 (en) Therapeutic T cells
ZA201704521B (en) Treatment of ocular conditions using progenitor cells
GB201519331D0 (en) Treatment paradigm
ZA201608406B (en) Enzyme treatment composition
IL281185A (en) Treatment of diabetic peripheral neuropathy using placental cells
GB201517329D0 (en) Diabetes gene therapy
IL267231A (en) Methods of treating diseases associated with ilc2 cells
EP3271017A4 (en) Treatment of skin conditions
GB201601456D0 (en) Improvements relating to retinal treatment
GB201511752D0 (en) Treatment of post-consumer bales